Market sentiment signals for Ovid Therapeutics (OVID): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
12 analysts
Options Flow (P/C)
0.57
More calls — Bullish
Avg Consensus PT
$5
+117.9%
Highest Price Target
$9
+312.8%
Lowest Price Target
$1
-45.0%
Short Interest
11.1%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | Cantor Fitzgerald | Imogen Mansfield— | — | — | Initiate | Overweight |
| Oct 6, 2026 | Guggenheim | Delma Caiati— | +221.1% | $7 | Initiate | Buy |
